Successful treatment of amyopathic dermatomyositis with topical tacrolimus [4]

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 595-596

  Ueda, M ^a   Makinodan, R ^a   Matsumura, M ^a   Ichihashi, M ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; CORTICOSTEROID; DAPSONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MUSCLE ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANAMNESIS; ATOPIC DERMATITIS; CANCER SCREENING; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DIAGNOSTIC TEST; DISEASE COURSE; DRUG INHIBITION; DRUG MEGADOSE; ELECTROMYOGRAPHY; ERYTHEMA; FEMALE; HELPER CELL; HUMAN; LABORATORY TEST; LETTER; LONG TERM CARE; MUSCLE WEAKNESS; MYOSITIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SKIN BIOPSY; SKIN DEFECT; T LYMPHOCYTE; TH1 CELL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0037364125     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05209_4.x     Document Type: Letter

References (8)

1. Dawkins MA, Jorizzo JL, Walker FO et al. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol 1998; 38: 397-404.
2. Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 1999; 11: 475-82.
3. Caproni M, Cardinali C, Parodi A et al. Amyopathic dermatomyositis. A review by the Italian group of immunodermatology. Arch Dermatol 2002; 138: 23-7.
4. Jorizzo JL. Dermatomyositis. Practical aspects. Arch Dermatol 2002; 138: 114-16.
5. Gelber AC, Nousari HC, Wigley FM. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J Rheumatol 2000; 27: 1542-5.
6. Cohen JB, Cutaneous involvement of dermatomyositis can respond to dapsone therapy. Int J Dermatol 2002; 41: 182-4.
7. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 2002; 20: 387-408.
8. Homey B. Assmann T, Vohr HW et al. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. J Immunol 1998; 160: 5331-40.